top of page

RBC Global Healthcare Conference: Rubedo Life Sciences is the first company to be in the clinic with an GPX4 modulator. They are announcing data today for the first time in actinic keratosis

  • May 19
  • 1 min read

CEO Frederick Beddingfield says they saw a 46% reduction in the AK count in 4 weeks in the first 18 actinic keratosis patients evaluated. He describes the science and what is next.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page